These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 23946621

  • 1. Comparison of adverse events and hospital length of stay associated with various amphotericin B formulations: sequential conventional amphotericin b/lipid versus lipid-only therapy for the treatment of invasive fungal infections in hospitalized patients.
    Wade RL, Chaudhari P, Natoli JL, Taylor RJ, Nathanson BH, Horn D.
    P T; 2013 May; 38(5):278-87. PubMed ID: 23946621
    [Abstract] [Full Text] [Related]

  • 2. Outcomes associated with conventional versus lipid-based formulations of amphotericin B in propensity-matched groups.
    Campbell RS, Chaudhari P, Hays HD, Taylor RJ, Nathanson BH, Bozzette SA, Horn DL.
    Clinicoecon Outcomes Res; 2013 May; 5():507-17. PubMed ID: 24187506
    [Abstract] [Full Text] [Related]

  • 3. Nephrotoxicity and other adverse events among inpatients receiving liposomal amphotericin B or amphotericin B lipid complex.
    Wade RL, Chaudhari P, Natoli JL, Taylor RJ, Nathanson BH, Horn DL.
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):361-7. PubMed ID: 23774005
    [Abstract] [Full Text] [Related]

  • 4. Budget impact analysis of liposomal amphotericin B and amphotericin B lipid complex in the treatment of invasive fungal infections in the United States.
    Yang H, Chaudhari P, Zhou ZY, Wu EQ, Patel C, Horn DL.
    Appl Health Econ Health Policy; 2014 Feb; 12(1):85-93. PubMed ID: 24385260
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Amphotericin B formulations: a comparative review of efficacy and toxicity.
    Hamill RJ.
    Drugs; 2013 Jun; 73(9):919-34. PubMed ID: 23729001
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacoeconomic analysis of amphotericin B lipid complex versus liposomal amphotericin B in the treatment of fungal infections.
    Kuti JL, Kotapati S, Williams P, Capitano B, Nightingale CH, Nicolau DP.
    Pharmacoeconomics; 2004 Jun; 22(5):301-10. PubMed ID: 15061680
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Frequency and Associated Factors of Amphotericin B Nephrotoxicity in Hospitalized Patients in Hematology-Oncology Wards in the Southwest of Iran.
    Karimzadeh I, Heydari M, Ramzi M, Sagheb MM.
    Nephrourol Mon; 2016 Sep; 8(5):e39581. PubMed ID: 27896234
    [Abstract] [Full Text] [Related]

  • 13. The evaluation of frequency of nephrotoxicity caused by liposomal amphotericin B.
    Kato H, Hagihara M, Yamagishi Y, Shibata Y, Kato Y, Furui T, Watanabe H, Asai N, Koizumi Y, Mikamo H.
    J Infect Chemother; 2018 Sep; 24(9):725-728. PubMed ID: 29773439
    [Abstract] [Full Text] [Related]

  • 14. Comparison of nephrotoxicity associated to different lipid formulations of amphotericin B: a real-life study.
    Falci DR, da Rosa FB, Pasqualotto AC.
    Mycoses; 2015 Feb; 58(2):104-12. PubMed ID: 25590436
    [Abstract] [Full Text] [Related]

  • 15. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients.
    Prentice HG, Hann IM, Herbrecht R, Aoun M, Kvaloy S, Catovsky D, Pinkerton CR, Schey SA, Jacobs F, Oakhill A, Stevens RF, Darbyshire PJ, Gibson BE.
    Br J Haematol; 1997 Sep; 98(3):711-8. PubMed ID: 9332329
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of liposomal amphotericin B versus an amphotericin B lipid complex on liver histopathology in patients with hematologic malignancies and invasive fungal infections: a retrospective, nonrandomized autopsy study.
    Chamilos G, Luna M, Lewis RE, Chemaly R, Raad II, Kontoyiannis DP.
    Clin Ther; 2007 Sep; 29(9):1980-6. PubMed ID: 18035197
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.